Westchester Capital Management (New York)’s NEOPHOTONICS CORP NPTN Stock Holding History

Westchester Capital Management (New York)’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-866,717	Closed	-$13.6M	–	537
2022 Q2	$13.6M	Sell	866,717 -591,970	-41%	-$9.04M	0.38%	45
2022 Q1	$22.2M	Buy	1,458,687 +578,879	+66%	+$8.82M	0.6%	37
2021 Q4	$13.5M	Buy	+879,808	New	+$11.6M	0.38%	35

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Westchester Capital Management (New York)'s NPTN Position: Q3 2022 in Review

Westchester Capital Management (New York) sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 866,717 shares — an estimated $13.6M sold.

Westchester Capital Management (New York) first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $22.2M in Q1 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Westchester Capital Management (New York) reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 866,717 NEOPHOTONICS CORP shares in Q3 2022, an estimated $13.6M.
Westchester Capital Management (New York) first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
Westchester Capital Management (New York)'s NEOPHOTONICS CORP position peaked at $22.2M in Q1 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2022, filed 15 Nov 2022.